NCT07478952 2026-03-18A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of AgeModernaTX, Inc.Phase 1 Not yet recruiting120 enrolled
NCT04554914 2026-02-20A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated DiseasesPierre Fabre MedicamentPhase 2 Recruiting190 enrolled